A Long-term Observational Study in Participants Who Have Received PBGENE-HBV (ELIMINATE-B)

Precision BioSciences

Status: Not yet enrolling

Conditions: Chronic HBV Infection

Treatments: Biological: PBGENE-HBV

Study type: Observational

Funder types: Industry

Identifiers

NCT07254208

PBGENE-HBV-02

Details and patient eligibility

About

Participants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.

Full description

This is a LTFU observational study designed to evaluate the safety of PBGENE-HBV in participants previously exposed to PBGENE-HBV. This study protocol does not include administration of PBGENE-HBV.

Enrollment: 45 estimated patients

Sex: All

Ages: 19 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Participant has received at least 1 dose of PBGENE-HBV investigational product in a prior clinical study
2. Participant, or their legally authorized representative, has provided signed informed consent.

Exclusion criteria

• N/A